PATENT CLAIM ANALYSIS

Application Number: 15979849
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["544", "331000"]

Abstract:
Object of the present invention is a process for the preparation of the pharmaceutical active ingredient Nilotinib free base or Nilotinib dihydrochloride dihydrate by means of an improved crystallization procedure.

Claim (Index 10):
The process according to  claim 1 , wherein the compound of formula (I) obtained in step (d) has X-ray powder diffraction pattern with characteristic peaks expressed in 2-Theta values (2\u03b8) at: 9.0\u00b10.1, 13.0\u00b10.1, 13.8\u00b10.1, 16.7\u00b10.1, 17.8\u00b10.1, 18.3\u00b10.1, 19.6\u00b10.1, 20.9\u00b10.1, 23.9\u00b10.1, and 25.7\u00b10.1.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 93.0
- Lexical Diversity: 1.19231
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13397640', '14660628', '14786902', '15502715', '15518895']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7856833146887552
- 35 USC 102 Novelty (BERT): 0.4824189006613617
- Combined Prediction Score: 0.7553568732860159
- Mean Citation Score: 205.370852
- Max Citation Score: 211.86151
- Similarity Product: 165.19198907087926

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test